These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 25958247)

  • 1. Synthesis and studies on the mGluR agonist activity of FAP4 stereoisomers.
    Ivashkin P; Lemonnier G; Tora AS; Pin JP; Goudet C; Jubault P; Pannecoucke X
    Bioorg Med Chem Lett; 2015 Jun; 25(12):2523-6. PubMed ID: 25958247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Α-amino-β-fluorocyclopropanecarboxylic acids as a new tool for drug development: synthesis of glutamic acid analogs and agonist activity towards metabotropic glutamate receptor 4.
    Lemonnier G; Lion C; Quirion JC; Pin JP; Goudet C; Jubault P
    Bioorg Med Chem; 2012 Aug; 20(15):4716-26. PubMed ID: 22750138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enantioselective preparation of ring-fused 1-fluorocyclopropane-1-carboxylate derivatives: en route to mGluR 2 receptor agonist MGS0028.
    Zhang F; Song ZJ; Tschaen D; Volante RP
    Org Lett; 2004 Oct; 6(21):3775-7. PubMed ID: 15469346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of APTCs (aminopyrrolidinetricarboxylic acids): identification of a new group III metabotropic glutamate receptor selective agonist.
    Schann S; Menet C; Arvault P; Mercier G; Frauli M; Mayer S; Hubert N; Triballeau N; Bertrand HO; Acher F; Neuville P
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4856-60. PubMed ID: 16828551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of 1-amino-2-phosphonomethylcyclopropanecarboxylic acids, new group III metabotropic glutamate receptor agonists.
    Sibille P; Lopez S; Brabet I; Valenti O; Oueslati N; Gaven F; Goudet C; Bertrand HO; Neyton J; Marino MJ; Amalric M; Pin JP; Acher FC
    J Med Chem; 2007 Jul; 50(15):3585-95. PubMed ID: 17602546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New 4-Functionalized Glutamate Analogues Are Selective Agonists at Metabotropic Glutamate Receptor Subtype 2 or Selective Agonists at Metabotropic Glutamate Receptor Group III.
    Huynh TH; Erichsen MN; Tora AS; Goudet C; Sagot E; Assaf Z; Thomsen C; Brodbeck R; Stensbøl TB; Bjørn-Yoshimoto WE; Nielsen B; Pin JP; Gefflaut T; Bunch L
    J Med Chem; 2016 Feb; 59(3):914-24. PubMed ID: 26814576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo.
    Gasparini F; Bruno V; Battaglia G; Lukic S; Leonhardt T; Inderbitzin W; Laurie D; Sommer B; Varney MA; Hess SD; Johnson EC; Kuhn R; Urwyler S; Sauer D; Portet C; Schmutz M; Nicoletti F; Flor PJ
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1678-87. PubMed ID: 10336568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of the four isomers of 4-aminopyrrolidine-2,4-dicarboxylate: identification of a potent, highly selective, and systemically-active agonist for metabotropic glutamate receptors negatively coupled to adenylate cyclase.
    Monn JA; Valli MJ; Johnson BG; Salhoff CR; Wright RA; Howe T; Bond A; Lodge D; Spangle LA; Paschal JW; Campbell JB; Griffey K; Tizzano JP; Schoepp DD
    J Med Chem; 1996 Jul; 39(15):2990-3000. PubMed ID: 8709133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-Aminocyclopropane-1-carboxylic acid derivatives: a new, general synthesis and NMDA receptor complex binding affinity study.
    Spadoni G; Balsamini C; Bedini A; Mugnaini M
    Farmaco; 1993 Dec; 48(12):1663-74. PubMed ID: 8135990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pharmacological characterization of aminocyclopentanetricarboxylic acids: new tools to discriminate between metabotropic glutamate receptor subtypes.
    Acher FC; Tellier FJ; Azerad R; Brabet IN; Fagni L; Pin JP
    J Med Chem; 1997 Sep; 40(19):3119-29. PubMed ID: 9301676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effects of group II metabotropic glutamate receptor agonist DCG-IV on hippocampal neurons in transient forebrain ischemia.
    Yoshioka H; Sugita M; Kinouchi H
    Neurosci Lett; 2009 Sep; 461(3):266-70. PubMed ID: 19549561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A virtual screening hit reveals new possibilities for developing group III metabotropic glutamate receptor agonists.
    Selvam C; Oueslati N; Lemasson IA; Brabet I; Rigault D; Courtiol T; Cesarini S; Triballeau N; Bertrand HO; Goudet C; Pin JP; Acher FC
    J Med Chem; 2010 Apr; 53(7):2797-813. PubMed ID: 20218620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of Group II/III metabotropic glutamate receptors attenuates LPS-induced astroglial neurotoxicity via promoting glutamate uptake.
    Zhou F; Yao HH; Wu JY; Yang YJ; Ding JH; Zhang J; Hu G
    J Neurosci Res; 2006 Aug; 84(2):268-77. PubMed ID: 16752416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular recognition of metabotropic glutamate receptor type 1 (mGluR1): synergistic understanding with free energy perturbation and linear response modeling.
    Kang SG; Das P; McGrane SJ; Martin AJ; Huynh T; Royyuru AK; Taylor AJ; Jones PG; Zhou R
    J Phys Chem B; 2014 Jun; 118(24):6393-404. PubMed ID: 24635567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2,3-Ethylene- and 2,3-trimethylene-bridged analogues of the group III metabotropic glutamate receptor ligand 2-amino-4-phosphonobutanoic acid.
    Johnson RL; Rao KS
    Bioorg Med Chem Lett; 2005 Jan; 15(1):57-60. PubMed ID: 15582410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, molecular modeling studies, and preliminary pharmacological characterization of all possible 2-(2'-sulfonocyclopropyl)glycine stereoisomers as conformationally constrained L-homocysteic acid analogs.
    Pellicciari R; Marinozzi M; Macchiarulo A; Fulco MC; Gafarova J; Serpi M; Giorgi G; Nielsen S; Thomsen C
    J Med Chem; 2007 Sep; 50(19):4630-41. PubMed ID: 17725337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the absolute configuration of phosphinic analogues of glutamate.
    Commare B; Rigault D; Lemasson IA; Deschamps P; Tomas A; Roussel P; Brabet I; Goudet C; Pin JP; Leroux FR; Colobert F; Acher FC
    Org Biomol Chem; 2015 Jan; 13(4):1106-12. PubMed ID: 25417857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailability.
    Ornstein PL; Bleisch TJ; Arnold MB; Kennedy JH; Wright RA; Johnson BG; Tizzano JP; Helton DR; Kallman MJ; Schoepp DD; Hérin M
    J Med Chem; 1998 Jan; 41(3):358-78. PubMed ID: 9464367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical pocket close to the glutamate binding site of mGlu receptors opens new possibilities for agonist design.
    Acher FC; Selvam C; Pin JP; Goudet C; Bertrand HO
    Neuropharmacology; 2011 Jan; 60(1):102-7. PubMed ID: 20621106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 4a metabotropic glutamate receptor: identification of new potent agonists and differentiation from the L-(+)-2-amino-4-phosphonobutanoic acid-sensitive receptor in the lateral perforant pathway in rats.
    Johansen PA; Chase LA; Sinor AD; Koerner JF; Johnson RL; Robinson MB
    Mol Pharmacol; 1995 Jul; 48(1):140-9. PubMed ID: 7623768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.